Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
6th grade Avg
|
|
New words:
ago, anemia, aware, Bare, cancellation, carryforward, chemistry, Chief, cumulative, cytogenetic, decline, denominated, depth, distributor, enabled, ENL, erythema, Europe, experience, Fee, foregoing, immunomodulatory, industry, inhibitor, judgment, judgmental, leprosum, leverage, line, Medicaid, milligram, myelodyplastic, nodosum, nominated, offering, opposed, partnership, PDUFA, portion, post, prelaunch, Prescription, priority, proprietory, rapid, recovery, relevant, retain, schedule, specific, strong, structure, submitted, Unauditied, uniquely, Unregistered, User, volume, widely, write
Removed:
alkeran, convert, focalin, institutional, nature, qualified, release, REVLIMID, targeted, THALOMID
Filing tables
Filing exhibits
Related press release
CELG similar filings
External links